InvestorsHub Logo
Followers 70
Posts 11742
Boards Moderated 0
Alias Born 01/05/2018

Re: None

Thursday, 01/10/2019 8:55:48 PM

Thursday, January 10, 2019 8:55:48 PM

Post# of 403648
Very good read:

https://finance.yahoo.com/news/big-pharma-ceos-indicate-more-145602838.html?.tsrc=applewf

Excerpts I find appealing -

"Big pharma companies are cash rich following the tax overhaul in 2017, which reduced the tax rate. The high premiums in the above deals also suggest the same. Moreover, the pullback in biotech stocks towards the end of 2018 lowered valuations of these companies, making them attractive buyout targets."

Biotech giant Amgen’s AMGN CEO, Robert Bradway said that the company’s strong balance sheet and cash flow should allow it to expand its portfolio by “acquiring or in-licensing attractive innovation.” AbbVie’s vice chairman and president, Mike Severino showed interest in strengthening the company’s pipeline through “strategic licensing, acquisition and partnering activity.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News